The global intravenous access device market was valued at US$ 34,100.7 million in 2016 and is expected to witness a robust CAGR of 6.6% during the forecast period (2017-2025).
Intravenous access device can be implanted under the skin which allows the medication to be delivered directly into large veins. Large veins clot less likely and so intravenous access devices can be left inside for long periods. Intravenous access devices are small, flexible tubes placed in large veins for people who require frequent access to the bloodstream. These devices are often also referred as venous access ports or catheters as they allow access to the veins without the use of deep needle stick. Placement of intravenous access devices is usually in one of the large veins of the chest or neck where they can remain in place for long periods such as weeks, months or even longer.
Increase in prevalence of diabetes, road accidents and increase in number of surgical procedures. As per the stats published by Centers for Disease Control and Prevention in the year 2016 more than 29 million Americans are living with diabetes, and 86 million are living with pre-diabetes.
Rise in incidences of different disease is expected to fuel the growth of the intravenous access devices market in the near future.
Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/567
North America accounts for the largest share in the global intravenous access devices market, followed by Europe. This mainly attributed to rapidly aging population, increase in the incidence rate of various disease such as cancer, kidney failure, diabetes and other life style inflicted diseases are some of the major factors that are expected to drive the intravenous access market. As per the stats published by Centers for Disease Control and Prevention (CDC), in 2012, around 29.1 people were living with diabetes in the U.S. Furthermore, in 2012, 1.7 million people were newly diagnosed for diabetes in U.S.
The intravenous access devices market is expected to show high growth rate in Asia-Pacific region over the forecast period supported by increase in prevalence rate of lifestyle disease such as diabetes. According to World Health Organization (WHO), in 2016, around 110 million people were living with diabetes in China and this number is expected to reach 150 million in 2040 due to unhealthy habits and lack of physical activity.
Also, the intravenous access device are used for administrating all drugs such as antipyretics, antibiotics, and analgesics is expected to raise the demand for the intravenous access device in developed and emerging regions during forecast period, as various drugs are used to treat the patients to get cure rapidly, as the drug can be directly inserted into the body through veins without any contamination. Also, intravenous access devices can be used for longer period of time for frequent intake of drugs.
Increase in preference of intravenous access devices for diagnosis of the disease by advance technology is expected to favor the growth of intravenous access devices market
Intravenous access devices are used to perform diagnostic test, blood sampling, blood transfusion, reading central venous pressure and fluid infusion. Intravenous access device is also attributed to rapidly aging population. According to National Institute on Aging in 2010 it was estimated that 524 million people were aged 65 or older that is 8% of the world's population and by 2050, which is expected to nearly triple the number to 1.5 billion, representing 16% of the world's population. This above statistics is expected favor the growth of intravenous access devices market. Whereas latest techniques, such as ultrasound-guided catheter tip have helped to increase the efficiency of these devices.
Click here to know more about this publish report: https://www.coherentmarketinsights.com/market-insight/intravenous-access-devices--market-567
Some major players operating in the intravenous access devices market includes Becton, Dickinson and Company, B. Braun Melsungen AG, Teleflex, Inc., C.R. Bard, Inc., Fresenius Medical Care, Smiths Medical, Hospira, Inc., Covidien Plc, Fresenius Medical Care AG & Co., and Baxter International.
Few growth restraining factors are due to prolonged hospitalization required before the intravenous access device is inserted in the body and prolonged placement of the device is limiting the growth of intravenous access device market.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The global intravenous access device market was valued at US$ 34,100.7 million in 2016 and is expected to witness a robust CAGR of 6.6% during the forecast period (2017-2025). here
News-ID: 753095 • Views: 171
More Releases from Medical Devices Industry
Cataract Surgery Devices Market - Global Industry Insights 2017 - 2025
Increasing incidence and prevalence of ocular diseases to propel the growth of global cataract surgery devices market Increasing prevalence of the ocular disorders is the major driver for the growth of global cataract surgery devices market. This disease is prevalent worldwide and is the major cause of blindness across the globe. According to All About Vision Media, A National Supporter and Sponsor of Optometry Giving Sight, cataract is the principle cause
Particulate Respirators Market Evolving Industry Trends and key Insights by 2020
Patient suffering from SARS or their surrounding people are the target population for particulate respirators Particulate respirators are medical devices, which helps to protect one from harmful particles present in the air or dust or harmful fumes. Such harmful dust usually spread through severe acute respiratory syndrome (SARS). SARS is a respiratory syndrome commonly spread among symptomatic individuals, by person-to-person contact, or when the person sneezes or coughs, thereby infecting
Sleeping Aids Market - Global Industry Insights, Trends, Outlook, and Opportunit …
Sleeping aids, also known as hypnotics are sleeping pills or devices, which are used to induce sleep. It is used in the treatment of various sleeping disorders such as narcolepsy, sleep apnea, and insomnia, which are caused due to factors such as psychiatric disorders (Depression and anxiety), environmental problems (light, noise and extreme temperatures) medical issues (asthma) and others. Sleeping aid medications include non-benzodiazepines, antidepressants, and antipsychotics for the treatment
Organ Preservation Market - Global Industry Insights, 2017-2025
Organ preservation involves removal of organs from the bodies, which are then stored for transplantation. Organ preservation systems are exclusively prepared and maintained according to the biological environment (temperature and oxygen) needed to store particular organs. Different body organs require specific and suitable storage conditions to maintain their anatomical and physiological processes. Important parameters in organ preservation include delivering of high quality organs to the donors, matching the patient and
More Releases for Intravenous
Intravenous (IV) Solutions Market
The Global Intravenous (IV) Solution Market is expected to reach USD 11,511.2 million by 2022 and is expected to grow at a CAGR of 7.69% during the forecast period 2016-2022. The factors which drive the growth of the market are the rising prevalence of chronic diseases, rising acceptance of vitamin C intravenous treatment therapy to treat colorectal cancer. Key Finding The global Intravenous (IV) Solution market and is expected to reach USD
Intravenous Solutions Market Opportunity Analysis, 2026
Intravenous solutions are the chemically prepared fluids, which are administered in the body through venous circulation to maintain or replace the lost body fluid level. There are various types of IV solutions that have different effects on a human body. Majority of intravenous solutions constitute of solvent and solute out of which solvents are sterile water and solutes are electrolytes such as sodium, potassium, and chloride. Intravenous solutions market is
Intravenous Product Packaging Market -
Global healthcare sector continues to develop at an impressive rate. As a result, packaging marketplace is undergoing huge changes with specialized focus on offering innovative packaging tools/products to pharmaceutical industry. One such core product that offers lucrative market opportunities for packaging companies is intravenous products. Download PDF Brochure For Future Advancements@ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14075 Intravenous product such as catheters and IV fluid bags are mainly used to prevent and treat various chronic illness
Intravenous Iron Drugs Market - Transformation Overview 2025
Intravenous Iron Drugs Market: Snapshot Iron is one of the most significant minerals required for the correct working of human bodies. Iron insufficiency prompts various medical problems, for example, anemia and could have a grave and direct association with the several of hospitalizations and deaths. The global market for intravenous drugs is foreseen to display a solid CAGR over the report's forecast period attributable to the rising pervasiveness of anemia cases
Intravenous Immunoglobulin (IVIg) Market Professional Survey Report
The term “immunoglobulin” refers to the breakdown of blood plasma that contains antibody. IVIg is a blood product which is administered intravenously. It contains polyvalent IgG antibodies which are extracted from the plasma of more than thousand of blood donors. Individuals who are unable to produce adequate amount of antibodies, such as patients with common variable immunodeficiency, Wiskott Aldrich Syndrome, X-linked agammaglobulinemia and other forms of hypogammaglobulinemia, get benefit from
Peripheral Intravenous Catheter Market
New research report offers a comprehensive analysis of the “Peripheral Intravenous Catheter Market: Asia Pacific Regional Market to Witness the Fastest Growth Throughout the Forecast Period: Global Industry Analysis & Opportunity Assessment, 2016-2021“The main objective of this report is to deliver insightful information and clear-cut facts pertaining to the growth trajectories of the market. Request to view Sample Report @ https://www.mrrse.com/sample/2827 Peripheral intravenous catheter is a sophisticated medical device widely used to